Discover how rimegepant (Nurtec ODT) works for both migraine treatment and prevention. Learn about the approved age range, ...

Pfizer Inc. (NYSE:PFE) Q4 2025 Earnings Call Transcript February 3, 2026 Pfizer Inc. beats earnings expectations. Reported ...

For the full year of 2025, Pfizer posted revenue of 62.6 billion dollars and an adjusted diluted EPS of 3.22 dollars, beating the consensus estimates polled by FactSet, which had anticipated revenue ...

Axsome Therapeutics AXSM has been witnessing a strong sales uptake for its lead marketed drug, Auvelity (AXS-05), which is approved for treating major depressive disorder. Since its launch in the ...

Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its fourth quarter and full year 2025 financial results on Wednesday, February 11, 2026 before the U.S. financial markets open.

Pfizer Balances COVID Drag With Pipeline Momentum in Latest Earnings Call The overall tone of Pfizer Inc.’s latest earnings call was cautiously optimistic, with management emphasizing underlying ...

Pharmaceutical companies hiked prices on hundreds of drugs so far in January, ushering in 2026 with steeper costs for everything from the COVID-19 vaccine to Ozempic despite the Trump administration's ...